Table 1.
Clinical characteristics
| OSA + CAD (n = 21) |
OSA (n = 20) |
P VALUE | |
|---|---|---|---|
| Demographics | |||
| Gender (female/male) | 5/16 | 3/17 | – |
| Age (years) | 61 ± 11 | 54 ± 12 | 0.05 |
| Body mass index (kg/m2) | 35 ± 7 | 33 ± 6 | 0.39 |
| Medical history | |||
| Hypertension | 19 (90%) | 13 (65%) | 0.17 |
| Hypercholesterolemia | 17 (81%) | 5 (25%) | <0.001 |
| Diabetes mellitus | 10 (48%) | 5 (25%) | 0.23 |
| Arrhythmia | 6 (29%) | 1 (5%) | 0.21 |
| Stroke | 2 (10%) | 0 | 0.61 |
| Myocardial infarction | 12 (57%) | 0 | <0.001 |
| COPD | 4 (19%) | 2 (10%) | 0.63 |
| Medication | |||
| Nitrates | 3 (14%) | 0 | 0.45 |
| β-blockers | 19 (90%) | 7 (35%) | <0.01 |
| Renin inhibitors | 0 (0%) | 1 (5%) | 0.81 |
| ACE inhibitors | 14 (67%) | 3 (15%) | <0.01 |
| Angiotensin receptor blockers | 3 (14%) | 5 (25%) | 0.58 |
| Diuretics | 11 (52%) | 5 (25%) | 0.14 |
| Calcium channel blockers | 9 (43%) | 5 (25%) | 0.34 |
| α-blockers | 1 (5%) | 2 (10%) | 0.79 |
| Cardiac and renal function | |||
| Left ventricular ejection fraction (%) | 59 ± 9 | 65 ± 2 | 0.05 |
| Glomerular filtration rate (ml/min) | 121 ± 53 | 137 ± 43 | 0.18 |
Note: Data are presented as mean ± SD or no. (%).